Addressing large, unmet global markets with innovative proprietary products More »
Capitalizing on high-value, emerging markets for pharmaceutical and diagnostic products More »
Identifying early-stage companies with potential to increase value for shareholders More »
OPKO continues to make progress with its program to build a company capable of long-term growth and increasing value to its investors.
Twelve Months Data Supporting Once-Weekly Dosing of hGH-CTP in Growth Hormone Deficient Pediatric Population to Be Presented at ENDO 2015 Conference more »
OPKO Announces Fourth Quarter Operating and Financial Results more »
OPKO to Announce Fourth Quarter and Full Year 2014 Financial Results on February 27, 2015 more »
OPKO Health is an opportunistic research and development company that targets large, high-growth markets.